Researchers at the Kolling Institute have welcomed the launch of Australia’s premier cancer clinical trials centre on the Royal North Shore Hospital campus.<\/p>\n\n\n\n
NORTH Sydney Trials and Research Van Norton Poche or NORTH STAR VNP has been made possible by a $20 million gift from the late Kay Van Norton Poche and her husband Greg.<\/p>\n\n\n\n
The centre is a ground-breaking partnership between Northern Sydney Local Health District and the world-renowned Memorial Sloan Kettering Cancer Centre in New York.<\/p>\n\n\n\n
NSLHD Chair of Research Professor Bruce Robinson said it will significantly expand access to the latest clinical trials for those in Sydney and across New South Wales, and then nationally.<\/p>\n\n\n\n
\n\u201cWe expect this wonderful new centre will offer hope to patients and their families across the country, improving treatments for cancer and even contributing to a cure.<\/p>\n\n\n\n
\u201cIt will mean communities, particularly those in rural and regional areas, will have access to the latest treatments and innovation, regardless of where they live.\u201d<\/p>\n<\/blockquote>\n\n\n\n
Three initial clinical trials will be underway within months, aiming to improve outcomes for people with head and neck cancers, breast cancers and upper gastric cancers.<\/p>\n\n\n\n
Leading bowel cancer researcher Professor Mark Molloy said cancer researchers at the Kolling Institute are looking forward to collaborating with the NORTH STAR VNP clinical trials.<\/p>\n\n\n\n
\n\u201cThis is an exciting opportunity to work with patient specimens obtained during clinical trials, which will allow us to discover prognostic and drug response biomarkers,\u201d he said.<\/p>\n\n\n\n
\u201cThrough these studies we will have a better understanding of the impact and function of new therapies, and how clinicians can optimise patient treatments.<\/p>\n\n\n\n
\u201cIt was encouraging to attend the launch of the new centre with so many national and international clinicians and researchers, and to witness the enthusiasm for this new partnership.<\/p>\n\n\n\n
\u201cWe look forward to it increasing research activity and the development of new targeted cancer treatments.\u201d<\/p>\n<\/blockquote>\n\n\n\n
If you would like to build on this legacy, you can donate to our fundraising partner, the\u00a0NORTH Foundation.<\/a><\/p>\n","protected":false},"author":1,"featured_media":2398,"menu_order":0,"template":"","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[],"research-group-tax":[],"primary-research-area":[],"class_list":["post-2397","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_NORTH-STAR-launch_w550_h380_fcrop.webp",550,380,false],"thumbnail":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_NORTH-STAR-launch_w550_h380_fcrop-150x150.webp",150,150,true],"medium":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_NORTH-STAR-launch_w550_h380_fcrop-300x207.webp",300,207,true],"medium_large":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_NORTH-STAR-launch_w550_h380_fcrop.webp",550,380,false],"large":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_NORTH-STAR-launch_w550_h380_fcrop.webp",550,380,false],"1536x1536":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_NORTH-STAR-launch_w550_h380_fcrop.webp",550,380,false],"2048x2048":["https:\/\/kollinginstitute.org.au\/staging\/wp-content\/uploads\/2025\/09\/thumb_Blog_NORTH-STAR-launch_w550_h380_fcrop.webp",550,380,false]},"uagb_author_info":{"display_name":"ict-wordpress-support@sydney.edu.au","author_link":"https:\/\/kollinginstitute.org.au\/staging\/author\/ict-wordpress-supportsydney-edu-au\/"},"uagb_comment_info":0,"uagb_excerpt":"Researchers at the Kolling Institute have welcomed the launch of Australia’s premier cancer clinical trials centre on the Royal North Shore Hospital campus. NORTH Sydney Trials and Research Van Norton Poche or NORTH STAR VNP has been made possible by a $20 million gift from the late Kay Van Norton Poche and her husband Greg.…","_links":{"self":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/news\/2397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/news\/2397\/revisions"}],"predecessor-version":[{"id":5399,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/news\/2397\/revisions\/5399"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/media\/2398"}],"wp:attachment":[{"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/media?parent=2397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/categories?post=2397"},{"taxonomy":"research-group-tax","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/research-group-tax?post=2397"},{"taxonomy":"primary-research-area","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/staging\/wp-json\/wp\/v2\/primary-research-area?post=2397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}